Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xcelience, IriSys in Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Xcelience, IriSys in Alliance

Contract service providers unite to streamline CMC, regulatory access.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Xcelience and IriSys have entered into a business alliance agreement to advance the ability to streamline access to CMC and regulatory expertise for North American pharmaceutical and biotechnology companies.

“IriSys has considerable experience moving compounds from early research to Phase I/II clinical trials in addition to offering full regulatory and strategic planning services,” said Derek Hennecke, chief executive officer and president of Xcelience. “This alliance provides a unique opportunity to leverage these strengths in conjunction with our own in a way that minimizes client risk, and maximizes client accessibility to the strategic locations of each company on the east and west coasts of the U.S.”

“Xcelience has a solid industry-wide reputation for accelerating the early drug development process; their particular solid dosage form technology expertise in filling an active pharmaceutical ingredient into capsules and their outstanding project management system are certainly complementary to IriSys,” said Gina Stack, president and chief executive officer of IriSys.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics